Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging.

PURPOSE The purpose of this study was to examine the effect of adjuvant chemotherapy on normal-appearing white matter in women with breast cancer. PATIENTS AND METHODS Ten patients with early-stage breast cancer who were treated with adjuvant chemotherapy and 9 age-, education-, and IQ-matched healthy controls were studied with magnetic resonance imaging. Diffusion tensor imaging was used to calculate fractional anisotropy (FA), a measure of white matter integrity. Measurements were made in the genu and splenium of the corpus callosum. Participants also completed measures of processing speed, depression, and anxiety. RESULTS Relative to controls, patients had slower processing speed and lower FA in the genu. Processing speed was positively correlated with FA in the genu. CONCLUSION The results of this pilot study suggest that adjuvant chemotherapy affects normal-appearing white matter in the genu of the corpus callosum and that this is related to the cognitive deficits experienced by patients.

[1]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[2]  Adolf Pfefferbaum,et al.  Microstructural but Not Macrostructural Disruption of White Matter in Women with Chronic Alcoholism , 2002, NeuroImage.

[3]  A. Howell,et al.  Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study , 2004, Psycho-oncology.

[4]  S. Rodenhuis,et al.  Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. , 1998, Journal of the National Cancer Institute.

[5]  I. Tannock,et al.  Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Tulsky,et al.  WAIS-III WMS-III Technical manual , 1977 .

[7]  P. Ganz,et al.  Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen , 2004, Journal of clinical and experimental neuropsychology.

[8]  J. Simon,et al.  White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. , 1998, AJNR. American journal of neuroradiology.

[9]  M. O’Sullivan,et al.  White matter damage on diffusion tensor imaging correlates with age-related cognitive decline , 2006, Neurology.

[10]  M. Parsons,et al.  Corpus Callosum Volume in Railroad Workers With Chronic Exposure to Solvents , 2006, Journal of occupational and environmental medicine.

[11]  C. Bielajew,et al.  A Meta-Analysis of the Neuropsychological Effects of Adjuvant Chemotherapy Treatment in Women Treated for Breast Cancer , 2006, The Clinical neuropsychologist.

[12]  P. Maruff,et al.  The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma , 2004, Cancer.

[13]  T. Nakano,et al.  No adverse effects of adjuvant chemotherapy on hippocampal volumein Japanese breast cancer survivors , 2005, Breast Cancer Research and Treatment.

[14]  William J Jagust,et al.  Estrogen- and tamoxifen-associated effects on brain structure and function , 2004, NeuroImage.

[15]  Yutaka Matsuoka,et al.  Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy , 2007, Cancer.

[16]  J. Simon,et al.  MR and proton spectroscopy of white matter disease induced by high-dose chemotherapy with bone marrow transplant in advanced breast carcinoma. , 1995, AJNR. American journal of neuroradiology.

[17]  G. Hortobagyi,et al.  Recent advances in adjuvant therapy of breast cancer. , 1999, Seminars in oncology.

[18]  P. V. van Zijl,et al.  Orientation‐independent diffusion imaging without tensor diagonalization: Anisotropy definitions based on physical attributes of the diffusion ellipsoid , 1999, Journal of magnetic resonance imaging : JMRI.

[19]  K. Ritchie,et al.  Lifelong endocrine fluctuations and related cognitive disorders. , 2005, Current pharmaceutical design.

[20]  M. Kim,et al.  5-fluorouracil-induced leukoencephalopathy in patients with breast cancer. , 2001, Journal of Korean medical science.

[21]  Andrew J Saykin,et al.  Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Ian F Tannock,et al.  Cognitive impairment associated with chemotherapy for cancer: report of a workshop. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  D. Head,et al.  Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. , 2004, Cerebral cortex.

[24]  R. Theriault,et al.  ‘Chemobrain’ in breast carcinoma? , 2004, Cancer.